Intermittent fasting (IF) comprises short-term caloric restriction and is an alternative to chronic caloric restriction, which, although an effective anticancer tool, may be difficult to sustain. Calorie restriction promotes anticarcinogenic adaptations such as decreased production of growth factors, inflammatory cytokines and reduced free radical-induced DNA damage . According to the International Food Information Council Foundation, IF has become the most popular diet in the last year, with cancer patients seeking advice from oncologists about its beneficial effects.
A recent review published in A Cancer Journal for Clinicians 2021 reports fasting to be an important factor causing a decrease in the growth factors and metabolites that help cancer cells survive. Why was the review conducted? To understand the impact of intermittent fasting on cancer prevention and treatment To…
